Clinicopathologic Analysis of Pituitary Adenoma - A Single Institute Experience
|
|
- Gordon Shon Kelly
- 5 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Neuroscience J Korean Med Sci ; : - Clinicopathologic Analysis of Pituitary Adenoma - A Single Institute Experience Hwa Jin Cho, * Hanna Kim, * Yoon Jin Kwak, Jeong Wook Seo, Sun Ha Paek, Chul-Ho Sohn, Jung Min Yun, Da Seu Ran Kim, Peter Kang, Peom Park, and Sung-Hye Park, Departments of Pathology, Neurosurgery, and Neuroradiology, Seoul National University Hospital and Seoul National University College of Medicine, Seoul; Department of Industrial Engineering, Ajou University, Suwon; Neuroscience Institute, Seoul National University College of Medicine, Seoul, Korea *Hwa Jin Cho and Hanna Kim equally contributed for this manuscript. Received: April Accepted: December Address for Correspondence: Sung-Hye Park, MD Department of Pathology, Seoul National University Hospital, College of Medicine, Daehak-ro, Jongno-gu, Seoul -7, Korea Tel: , Fax: shparknp@snu.ac.kr Pituitary adenoma (PA) is a common benign neuroendocrine tumor; however, the incidence and proportion of hormone-producing PAs in Korean patients remain unknown. Authors analyzed 6 surgically resected and pathologically proven pituitary lesions of the Seoul National University Hospital from 6 to. The lesions were categorized as: PAs (n =, 8.%), Rathke s cleft cysts (RCCs) (n =,.6%), inflammatory lesions (n = 8,.6%), meningiomas (n = ), craniopharyngiomas (n = ), granular cell tumors (n = ), metastatic renal cell carcinomas (n = ), germinomas (n = ), ependymomas (n = ), and unsatisfactory specimens (n =,.8%). PAs were slightly more prevalent in women (M: F = :.7) with a mean age of 8.8 yr (-8 yr). Immunohistochemical analysis revealed that prolactin-producing PAs (6.6%) and growth hormone-producing adenomas (.%) were the most common functional PAs. Plurihormonal PAs and nonfunctioning (null cell) adenomas were found in.% and.% of patients with PAs, respectively. The recurrence rate of PAs was.%, but nearly % for the remaining benign lesions such as RCCs..% of patients with PAs were treated by gamma-knife after surgery due to residual tumors or regrowth of residual tumor. In conclusion, the pituitary lesions and the proportions of hormone-producing PAs in Korean patients are similar to those of previous reports except nonfunctioning (null cell) PAs, which are unusually frequent. Keywords: Pituitary Gland; Pituitary Neoplasms; Pituitary Adenoma; Clinicopathological Study; Pituitary Hormone This research was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A) and National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. - 86). INTRODUCTION Pituitary adenoma (PA), comprising %-% of intracranial neoplasms, is the most common benign neuroendocrine tumor of the central nervous system (-). The prevalence of PAs in autopsy subjects has been reported to be %-% (6). In community-based cross-sectional studies, their prevalence is one per, population (, ). Most PAs found in autopsies are incidentaloma without clinical impact (). However, the exact incidence and proportion of hormone-producing PAs, especially in the Korean population, remain unknown. PAs are classified as functional or nonfunctional and divided into macroadenomas ( mm) and microadenomas ( < mm) according to tumor size (6). Patients with PAs present with a variety of signs and symptoms related to excess or impaired pituitary function and/or mechanical effects. In order of frequency, prolactin (PRL)-, growth hormone (GH)-, and adrenocorticotropic hormone (ACTH)-producing tumors are the most common functioning PAs that can cause functional changes in end organs. One-third of PAs are not associated with symptoms or signs of hormone excess. The majority of clinically nonfunctioning pituitary tumors are gonadotroph cell adenomas (7, 8). True nonfunctioning pituitary tumors are difficult to recognize until their growth results in symptoms such as headaches, visual disturbances, and cranial nerve palsies as a result of their mass effect, or hypopituitarism. In this study, we analyzed surgically resected and immunohistochemically evaluated PAs in our institute over 6 yr to determine the clinicopathological characteristics such as gender, age, symptoms, size, and proportion of hormonal subtypes of PAs in the Korean population. MATERIALS AND METHODS We analyzed 6 cases of surgically resected pituitary lesions The Korean Academy of Medical Sciences. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. pissn -8 eissn 8-67
2 Cho HJ, et al. Pituitary Adenoma from 6- and reviewed the patients medical records, pa thology reports, radiological findings and immunohistochemical studies retrieved from the Seoul National University Hospital (SNUH) archives. This research was approved by the Institutional Review Board (IRB) of SNUH (-8-7). Informed consents were waived by the IRB board. RESULTS In total, 6 cases of surgically resected and pathologically confirmed pituitary lesions were reviewed: PAs (n =, 8.%), Rathke s cleft cysts (RCCs) (n =,.6%), inflammatory lesions (n = 8,.6%), meningiomas (n =,.8%), craniopharyngiomas (n =,.8%), granular cell tumors (n = ), metastatic renal cell carcinomas (n = ), germinomas (n = ), ependymomas (n = ), and normal pituitary tissue or unsatisfactory specimens (n =,.8%) (Table ). Fig. depicts representative mi- croscopic findings. PAs were common in patients in their s to 6s (mean age: 8.8 yr), and there was female predominance at these ages; however, there was male predominance in patients under yr and over 7 yr (Fig., Table ). The mean ages at diagnosis of patients Table. Summary of surgically resected pituitary lesions in our hospital in 6- Pituitary lesion No Pituitary adenoma Rathke s cleft cyst Inflammatory lesion Meningioma Craniopharyngioma Granular cell tumor Metastatic renal cell carcinoma Germinoma Ependymoma Normal pituitary tissue or unsatisfactory specimen Total 8 6 % A B C D Fig.. Histopathological findings of PAs (H&E, ). (A) Sheet of monotonous cells with round nuclei and loss of normal lobular patterns in PA. (B) Rathke s cleft cyst lined by goblet cell-studded ciliated columnar epithelium, abutted by fibrocollagenous tissue with chronic inflammation. (C) Chronic hypophysitis with swollen anterior pituitary cells and massive lymphoplasma cell infiltration. (D) Sheet of eosinophilic cells with vesicular small round nuclei and abundant granular cytoplasm in granular cell tumor of the pituitary stalk
3 Table. Proportion of pituitary adenoma according to age, sex, and hormone production Age (yr) PRL GH FSH ACTH TSH LH Pluri-H Non-F Total (%) > Total (%) 7 (6.6) (.) 7 (8.8) (.) 7 (.7) (.) 6 (.%) 7 (.) () Mean age at Dx (yr) M:F ratio :.8 :. :.8 :. :. : :. :. :.7 PRL, Prolactin; GH, growth hormone; FSH, follicle-stimulating hormone; ACTH, adrenocorticotropic hormone; TSH, thyroid-stimulating hormone; LH, luteinizing hormone; Pluri-H, plurihormonal; Non-F, nonfunctional; Dx, diagnosis No of patients 7 6 Age distribution of pituitary adenomas Male Female Table. Presenting symptoms of patients with pituitary adenomas Presenting symptoms Proportion (%) Visual disorder* 7. Abnormal hormonal effect. Headache/nausea & vomiting/dizziness. Neurological deficit. Incidentaloma. Total *Visual disorder includes visual field defect, decreased visual acuity and diplopia Decade of age Fig.. Gender and age distribution of patients with PA. PA was most common in patients in their s to 6s, with female predominance noted at these ages; male predominance was noted in patients < yr and > 7 yr. with immunohistochemically proven prolactinoma (PRLomas), GH-producing PAs, follicle stimulating hormone (FSH)-producing PAs, adrenocorticotrophic hormone (ACTH)-producing PAs, thyroid stimulating hormone (TSH)-producing PAs, leuteinizing hormone (LH)-producing PAs, plurihormonal PAs, and nonfunctioning PAs were.,.6, 7.,., 6., 6.,.8, and.7 yr, respectively (Table ). Therefore, FSH producing PAs tended to occur in older patients and TSH producing PAs tended to develop in younger patients. In patients in their s with PA, women were more predominant (M:F = :.78) (Table ). However, the most PA types exhibited a female predominance (M:F = :.) except FSH-producing PAs (M:F = :.8). None of them had gonadotrophin induced symptoms, which might be associated with age and gender. All the gonadotrophin producing PAs occurred in old age (more than yr old), except one case ( yr old). And the patients with FSH-producing PA showed male predominance as mentioned above. The age and gender distributions for patients with PAs are shown in Fig.. Among PAs, PRL-producing adenomas were most common (6.6%), followed by GH-producing adenomas (.%). The remaining PAs were FSH- (8.8%), ACTH- (.%), TSH- (.7%), and LH- (.%) producing adenomas. Plurihormonal PAs produce more than one pituitary hormone, occurred in.% of patients. Nonfunctioning adenomas comprised.% of pituitary adenomas (Table ). Most of our cases (about %) were macroadenoma (diameter >. cm), which frequently involved the sellar and suprasellar area, and showed cavernous invasion. Clinically, the patients with PAs had been suffered from visual disorders (7.%), abnormal hormonal effects (.%), headaches/nausea and vomiting/dizziness (.%), neurological deficits (.%), but % of them was found incidentally (.%) (Table ). Seventy patients with PRL producing PAs had been suffered from more amenorrhea/galactorrhea (6%), headache/ dizziness (6%) and visual problems (%) and % was incidentally found. Thirty-nine patients with GH producing PAs had been suffered from acromegaly/gigantism (7.%), headache (.8%), decreased visual acuity (.%) and incidentaloma (7.7%). Thirty-nine patients with gonadotrophin (FSH or LH) producing PAs had suffered from visual problems (.6%), headache, nausea and vomiting and/or dizziness (8.%), incidentaloma (.7%), neurologic deficit (.6%) and panhypopituitarism (.6%), however, none of cases showed gonadotrophin related symptoms. Twenty-five patients with ACTH producing PAs had presented with visual symptoms (%) including decreased visual acuity, visual field defect and diplopia, headache & nausea (8%), amenorrhea and dysmenorrhea/galactorrhea (%), and incidentaloma (%), but Cushing syndrome was rare. Seven patients with TSH-producing PAs had presented 7
4 Table. The most common symptoms and percent of incidentaloma according to producing hormone of pituitary adenomas Producing hormones Most common symptoms Proportion (%) of incidentaloma All PAs Visual Sx* (7%), hormonal effect (.%), headache (.%). PRL Amenorrhea/galactorrhea (6%), headache (6%), visual Sx (%). GH Acromegaly (7.%), headache (.8%), visual Sx (.%) 7.7 Gonadotrophin (FSH or LH) Visual disorder (.6%), headache (8.%).7 ACTH Visual Sx (%), headache (8%), amenorrhea/galactorrhea (%). TSH Visual Sx (7.%), goiter (.%). Plurihormonal Acromegaly (6.%), visual Sx (7%), headache (.6%).7 Nonfunctioning Visual Sx (%), headache (7%). *Visual symptoms include visual field defect, decreased visual acuity, diplopia; Headache includes nausea and vomiting, and dizziness; Amenorrhea/galactorrhea include menstrual irregularity. Sx, symptoms. No of patients 8 6 Age distribution of RCC and PA RCC PA Decade of age Fig.. Age distribution of patients with Rathke s cleft cyst (RCC) as compared with that of pituitary adenomas (PAs). with visual problem (7.%) and one goiter (.%) and remaining one case (.%) was incidentally found. Sixty three patients with plurihormonal PAs had been suffered from acromegaly (6.%), visual problems (7.%), headache, nausea and vomiting, and dizziness (.6%), amenorrhea/galactorrhea (.%), and remaining was incidentalomas (.7%). One hundred seventy nine patients with nonfunctioning PAs had been suffered from visual problems (%), headache/nausea/dizziness (7%), ame norrhea/galactorrhea/dysmenorrhea (6%), and acromegaly (%), but % was incidentalomas. The common symptoms and percent of incidentaloma are summarized in Table. The median follow-up time for patients with PAs was.6 months (range:.7-7 months). During this follow-up period, 7 patients (.% of PAs) had tumor recurrence, most of them were surgically re-removed and some of them were treated by gamma knife surgery. Two most commonly recurrent tumors were nonfunctioning adenomas (.%) and FSH-producing tumors (.%). Six patients had more than two times tumor recurrence. In addition,.% of patients with PAs were treated by gamma knife surgery due to residual tumor or regrowth of residual tumor, which produce successful control of residual PAs. RCCs were also more common in women than in men (M:F = :.). The mean age of patients with RCCs was.8 yr (range: 6-78 yr). RCCs were most common in patients in their teens and twenties (Fig. ). The age distribution of patients with RCCs as compared with those with PAs is shown in Fig.. Inflammatory lesions were composed of chronic hypophysitis (n = ), cholesterol granulomas (n = ), chronic granulomatous inflammation (n = ) and aspergillosis (n = ). DISCUSSION The overall recorded incidence of PAs has been reported as per,, similar to the rate reported by the Central Brain Tumor Registry of the United States ( (). PA prevalence has been reported at 77.6 to ±. cases per, population in community-based cross-sectional studies (, ); women were more frequently affected than men (M:F =.:.) (). However, because few studies have reported these statistics for pituitary lesions in Korea, the exact incidence or prevalence of PAs in this population is unknown. In one of the largest series of PA studies, Nilsson et al. collected samples from,7 patients over yr and found that the age-standardized incidence of PA increased significantly from approximately 6 to cases per million inhabitants from 8 to, suggesting that the annual incidence of PA is increasing (). The median age was. ±.7 yr (). PA diagnosis was made by histological examination in 7.8%, radiological examination in.7%, clinical examination in.%, postmortem histological examination in.%, and surgery without histological examination in.7% of cases (). There are several reports about the natural history of nonfunctional PAs (, ). Men were more likely to present with multiple hormonal deficiencies than women (7% vs 8%), and premenopausal women tended to have smaller adenomas than men, but neither adenoma size nor invasion was associated with multiple hormonal deficiencies at presentation (). Premenopausal women with nonfunctional PAs generally have favorable hormonal outcomes after operation: postoperative hormonal recovery was observed in over one-third of cases, with the greatest recovery being in the gonadal axis of 6% of premenopausal women (). Despite the relatively high prevalence of incidentalomas and nonfunctional PAs, complications were fairly rare; however, functional adenomas and macroadenomas produce remarkable sequelae of late diagnosis or therapy-relat
5 ed adverse effects, such as visual field defects, hypopituitarism, or radiation change (, ). More accurate information about PAs may improve patient outcome in these cases. Clinicopathologically, PAs are benign tumors, and can be classified as functional (hormone-secreting) or nonfunctional. They cause pituitary dysfunctions such as adenoma-related hypersecretion or mass effect-related hypopituitarism. In addition, patients often present with visual field defect or loss of visual acuity or diplopia by oculomotor dysfunction, especially in cases of cavernous sinus infiltration. Fernandez et al. () carried out a community-based crosssectional study in a small UK town and found the proportion of PRLoma in.%, nonfunctioning PA in.%, acromegaly (ACRO) in 8.6%, corticotroph adenoma in.% and unknown functional status in.%. The distribution of each PA subtype was PRLoma, 7%; nonfunctioning PA, 8%; ACRO, %; corticotroph adenoma, %; and unknown functional status, %. The median age at diagnosis (yr) and duration of symptoms until diagnosis (yr) were PRLoma,. yr and. yr; nonfunctioning PA,. yr and.8 yr; ACRO, 7 yr and. yr; corticotroph adenoma, 7 yr and 7 yr. PRLoma was the most frequent PA diagnosed up to the age of 6 yr, while nonfunctioning PA was most common after 6 yr of age. Nonfunctioning PA predominated in men (7% of all men with PA) and PRLoma in women (76% of all women with PA). Fernandez et al. () also concluded that PAs were times more prevalent than previously thought. Here, we evaluated only surgically resected, biopsy-proven pituitary lesions from a single hospital with immunohistochemical studies of pituitary hormones. In our series, the most common surgically resected pituitary lesion was PA (8.%), similar to other reports (). PA was 8.6 times more common than RCC (.8%). PAs were most common in middle-aged female patients (mean age: 8.8 yr) (overall M:F = :.7), except FSH-producing PA, for which there was male predominance (M:F = :.8). The mean age of patients with PAs was yr older than that of RCCs. Immunohistochemical study in our series found that 7.6% of PAs were functional and the remaining PAs (.%) was nonfunctional, respectively. The most common functional PAs were PRL- (6.6%) and GH-producing adenomas (.%). The remaining PAs were FSH- (8.8%), ACTH- (.%), TSH- (.7%), and LH- (.%) producing adenomas. The proportion of immunohistochemically nonfunctional PAs we found was much frequent than that of previously reported cases (.% vs %) but the proportion of the remaining subtype was similar to that of previously reported (Table ) (6,, ). Pleurihormonal PAs was.%, which was also very similar to that of previous reports (up to.%). In our series, the mean age at diagnosis was lowest in the patients with TSH-producing PAs (6. yr) and highest in those with FSH-producing adenomas (7. yr) (Table ). The mean age at diagnosis of PRL- and GH-producing adenoma patients was. yr and.6 yr, respectively, and the mean age of patients with FSH-producing, and nonfunctioning PAs was the sixth decade (Table ). It is known that up to two third of the PAs presented with symptoms or signs of hormone excess. For example, thyrotropin (TSH)- secreting adenomas constitute approximately %-% of all pituitary tumors, resulting in central hyperthyroidism characterized by diffuse goiter, elevated circulating levels of free thyroid hormones, and non-suppressed serum TSH. In rare cases, gonadotropin-secreting tumors may result in ovarian hyperstimulation, testicular enlargement, or precocious puberty. However, in our series, only one fifth of the patients with PAs presented with hormone associated symptoms and signs and most of them were PRLoma or GH-producing adenomas. Our cases of TSH and gonadotrophin-secreting PAs rarely showed the symptoms or signs of the hormone excess. Our patients with PAs pre sented with visual disorders (7.%), abnormal hormonal effects (.%), headaches/nausea and vomiting or dizziness (.%), neurological deficits (.%), however,.% of PAs were discovered incidentally (Table ). Abnormal hormonal effects were presented in patients with hormone producing PAs, which were GH (acromegaly/gigantism in 7.%) and PRL-producing (amenorrhea/galactorrhea in 6%) and plurihormonal PAs (acromegaly in 6.%) (Table ). Since the remaining PAs did not show hormonal effect, immunohistochemical study is essential for the determination of hormonal subtype of PAs. The treatment of choice for PAs is trans-sphenoidal surgical resection, which is a relatively safe treatment option. Transsphenoidal surgery carries a low risk of mortality and surgical complications; surgery can improve visual field defects in almost 8% of patients (). Radiation therapy or gamma knife surgery is an option for recurrent tumors. The recurrence rate of PAs is usually not high (6.%-.8%), and has recently decreased remarkably (-6). In our series, the recurrence rate after surgery was.%; in particular, nonfunctional PAs had the highest recurrence rate. All recurrent or residual tumors in our series were removed by additional surgery or treated by gamma knife surgery (.% = 7/ cases). With gamma knife surgery, most of the residual or recurrent PAs were controlled. In conclusion, we found that PAs were most common in middle-aged women and that PRL- and GH- producing and plurihormonal PAs were the most common functional adenomas at our hospital. Since the remaining PAs rarely showed hormonal symptoms and signs, immunohistochemical study is essential for the determination of hormonal subtype of PAs. The recurrence rate was.% and the recurrence rate of the nonfunctioning and gonadotrophic hormone producing adenomas had higher than that of the other hormone producing PAs. The proportions of hormone-producing PAs and pituitary lesions in Korean patients were similar to those of previous reports except nonfunctioning (null cell) PAs which were more common in our series than previous reports (.% vs %) possibly due to
6 specimen bias because we analyzed surgically resected and immunohistochemistry proven cases only. DISCLOSURE The authors have no conflicts of interest to disclose. ORCID Hwa Jin Cho Jeong Wook Seo Jung Min Yun Sung-Hye Park REFERENCES. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer ; : 6-.. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B. Pituitary adenomas in Sweden between 8 and : incidence, survival, and mortality. J Clin Endocrinol Metab ; 8: -.. Daly AF, Burlacu MC, Livadariu E, Beckers A. The epidemiology and management of pituitary incidentalomas. Horm Res 7; 68: -8.. Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) ; 7: Daly AF, Tichomirowa MA, Beckers A. The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab ; : Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer ; 8: Krysiak R, Okopień B, Korzekwa M. Atypical pituitary tumors. Pol Merkur Lekarski ; : Chanson P, Brochier S. Non-functioning pituitary adenomas. J Endocrinol Invest ; 8: -.. Hemminki K, Försti A, Ji J. Incidence and familial risks in pituitary adenoma and associated tumors. Endocr Relat Cancer 7; : -.. Raappana A, Koivukangas J, Ebeling T, Pirilä T. Incidence of pituitary adenomas in Northern Finland in -7. J Clin Endocrinol Metab ; : Fernández-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Pérez L, Ponce de León-Lovatón PG, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab ; 6: -.. Caputo C, Sutherland T, Farish S, McNeill P, Ng KW, Inder WJ. Gender differences in presentation and outcome of nonfunctioning pituitary macroadenomas. Clin Endocrinol (Oxf) ; 78: Norberg L, Johansson R, Rasmuson T. Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours. Clin Endocrinol (Oxf) 8; 68: Murad MH, Fernández-Balsells MM, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, Lampropulos JF, Natividad I, Perestelo-Pérez L, Ponce de León-Lovatón PG, et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin Endocrinol (Oxf) ; 7: Terada T, Kovacs K, Stefaneanu L, Horvath E. Incidence, pathology, and recurrence of pituitary adenomas: study of 67 unselected surgical cases. Endocr Pathol ; 6: Paluzzi A, Fernandez-Miranda JC, Tonya Stefko S, Challinor S, Snyderman CH, Gardner PA. Endoscopic endonasal approach for pituitary adenomas: a series of patients. Pituitary. doi:.7/s
Imaging pituitary gland tumors
November 2005 Imaging pituitary gland tumors Neel Varshney,, Harvard Medical School Year IV Two categories of presenting signs of a pituitary mass Functional tumors present with symptoms due to excess
More informationImaging The Turkish Saddle. Russell Goodman, HMS III Dr. Gillian Lieberman
Imaging The Turkish Saddle Russell Goodman, HMS III Dr. Gillian Lieberman Learning Objectives Review the anatomy of the sellar region Discuss the differential diagnosis of sellar masses Discuss typical
More informationLaurie A. Loevner, MD
Laurie A. Loevner, MD Chief, Division of Neuroradiology UPHS Professor of Radiology, Otorhinolaryngology: Head & Neck Surgery, Neurosurgery, and Ophthalmology University of Pennsylvania Health System Disclosures
More information3/22/2017. Disclosure of Relevant Financial Relationships. Disclosure of Relevant Financial Relationships
Ki67 in Pituitary Tumors: What Information Could We Obtain? Robert Y. Osamura, MD International University of Health and Welfare Ki67 in Pituitary Tumors: What Information Could We Obtain? Robert Y. Osamura,
More informationSee the latest estimates for new cases of pituitary tumors in the US and what research is currently being done.
About Pituitary Tumors Overview and Types If you have been diagnosed with a pituitary tumor or worried about it, you likely have a lot of questions. Learning some basics is a good place to start. What
More informationPituitary Tumors and Incidentalomas. Bijan Ahrari, MD, FACE, ECNU Palm Medical Group
Pituitary Tumors and Incidentalomas Bijan Ahrari, MD, FACE, ECNU Palm Medical Group Background Pituitary incidentaloma: a previously unsuspected pituitary lesion that is discovered on an imaging study
More informationRadiotherapy approaches to pituitary tumors
Disclosures No relevant disclosures Radiotherapy approaches to pituitary tumors Pituitary Disorders: Advances in Diagnosis and Management Steve Braunstein, MD, PhD UCSF Department of Radiation Oncology
More informationDiseases of pituitary gland
Diseases of pituitary gland A brief introduction Anterior lobe = adenohypophysis Posterior lobe = neurohypophysis The production of most pituitary hormones is controlled in large part by positively and
More informationAccepted Preprint first posted on 1 August 2014 as Manuscript EJE The incidence rate of pituitary adenomas in Western Sweden
Page 1 of 26 Accepted Preprint first posted on 1 August 2014 as Manuscript EJE-14-0144 The incidence rate of pituitary adenomas in Western Sweden 2001-2011 Axel Tjörnstrand *, 1, Kerstin Gunnarsson *,
More informationR J M E Romanian Journal of Morphology & Embryology
Rom J Morphol Embryol 2011, 52(3 Suppl):1041 1045 ORIGINAL PAPER R J M E Romanian Journal of Morphology & Embryology http://www.rjme.ro/ Conventional examination versus immunohistochemistry in the prediction
More informationThe Pathology of Pituitary Adenomas. I have nothing to disclose 10/13/2016. Pituitary Disorders: Advances in Diagnosis and Management
The Pathology of Pituitary Adenomas Pituitary Disorders: Advances in Diagnosis and Management October 22, 2016 I have nothing to disclose Melike Pekmezci, MD University of California San Francisco Neuropathology
More informationPathology of pituitary gland. By: Shifaa Qa qa
Pathology of pituitary gland By: Shifaa Qa qa Sella turcica Adenohypophysis (80%): - epithelial cells - acidophil, basophil, chromophobe - Somatotrophs, Mammosomatotrophs, Corticotrophs, Thyrotrophs, Gonadotrophs
More informationPituitary adenomas are a diverse group of tumors arising from the. The Prevalence of Pituitary Adenomas. A Systematic Review
613 The Prevalence of Pituitary Adenomas A Systematic Review Shereen Ezzat, M.D. 1 Sylvia L. Asa, M.D., Ph.D. 2 William T. Couldwell, M.D. 3 Charles E. Barr, M.D., M.P.H. 4 William E. Dodge, M.S., M.B.A.
More informationHypothalamus & Pituitary Gland
Hypothalamus & Pituitary Gland Hypothalamus and Pituitary Gland The hypothalamus and pituitary gland form a unit that exerts control over the function of several endocrine glands (thyroid, adrenals, and
More informationProlactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234)
Prolactin-Secreting Pituitary Adenomas (Prolactinomas) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland.
More informationPITUITARY: JUST THE BASICS PART 2 THE PATIENT
PITUITARY: JUST THE BASICS PART 2 THE PATIENT DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and
More informationPituitary Adenomas: Evaluation and Management. Fawn M. Wolf, MD 10/27/17
Pituitary Adenomas: Evaluation and Management Fawn M. Wolf, MD 10/27/17 Over 18,000 pituitaries examined at autopsy: -10.6% contained adenomas (1.5-27%) -Frequency similar for men and women and across
More informationMetastasis. 57 year old with progressive Headache and Right Sided Visual Loss
Metastasis 1% of sellar/parasellar masses Usually occurs with known primary Can involve third ventricle, hypothalamus, infundibular stalk May be both supra-, intrasellar 57 year old with progressive Headache
More informationPituitary apoplexy 台北榮總內分泌新陳代謝科主治醫師林怡君
Pituitary apoplexy 台北榮總內分泌新陳代謝科主治醫師林怡君 Williams text book of endocrinology 11 th e Anterior pituitary hormone 10-20% of pituitary cells, increase to 40% during AP PRL releasing factors: TRH, oxytocin,
More informationEndocrinological Outcome Among Treated Craniopharyngioma Patients
Endocrinological Outcome Among Treated Craniopharyngioma Patients Afaf Al Sagheir, MD Head & Consultant, Section of Endocrinology/Diabetes Department of Pediatrics KFSH&RC Introduction Craniopharyngiomas
More informationoriginal article INTRODUCTION The prevalence estimates of pituitary adenomas (PAs) ABSTRACT
original article Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina Patricia Fainstein Day 1,
More informationA survey of pituitary incidentaloma in Japan
European Journal of Endocrinology (2003) 149 123 127 ISSN 0804-4643 CLINICAL STUDY A survey of pituitary incidentaloma in Japan Naoko Sanno, Ken ichi Oyama, Shigeyuki Tahara, Akira Teramoto and Yuzuru
More informationPituitary Macroadenoma with Superior Orbital Fissure Syndrome
1 CASE REPORT OPEN ACCESS Pituitary Macroadenoma with Superior Orbital Fissure Syndrome Tapan Nagpal, Ankit Singhania ABSTRACT Introduction: Pituitary adenomas are benign tumours which arise within the
More informationEndocrine part two. Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy
Endocrine part two Presented by Dr. Mohammad Saadeh The requirements for the Clinical Chemistry Philadelphia University Faculty of pharmacy Cushing's disease: increased secretion of adrenocorticotropic
More informationThe Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
Journal of Pathology and Translational Medicine 2016; 50: 419-425 ORIGINAL ARTICLE The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence Jee
More informationThe Characteristics of Incidental Pituitary Microadenomas in 120 Korean Forensic Autopsy Cases
J Korean Med Sci 2007; 22 (Suppl): S61-5 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences The Characteristics of Incidental Pituitary Microadenomas in 120 Korean Forensic Autopsy Cases To
More informationUrgent and Emergent Pituitary Conditions
Urgent and Emergent Pituitary Conditions PANKAJ A. GORE, MD DIRECTOR, BRAIN AND SKULL BASE T UMOR SURGERY PROVIDENCE B R AIN AND S PINE I NSTITUTE Urgent and Emergent Pituitary Conditions Neurosurgical
More informationPituitary gland diseases
Pituitary gland diseases Pituitary Gland Weight 600 mg Is located within the sella turcica Anatomically and functionally distinct anterior and posterior lobes Pituitary Development The pituitary originate
More informationVARIABLE THYROID-STIMULATING HORMONE DYNAMICS IN SILENT THYROTROPH ADENOMAS
Case Report VRILE THYROID-STIMULTING HORMONE DYNMICS IN SILENT THYROTROPH DENOMS Nigel Glynn, M 1 ; nne Marie Hannon, M 1 ; Michael Farrell, MD 2 ; Francesca rett, MD 2 ; Mohsen Javadpour, MD 3 ; mar gha,
More informationIntrasphenoidal Rathke's Cleft Cyst: Case presentation and review of the literature
Romanian Neurosurgery Volume XXX Number 4 2016 October - December Article Intrasphenoidal Rathke's Cleft Cyst: Case presentation and review of the literature Umit Kocaman, Muhammet Bahadir Yilmaz, Hakan
More informationACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST
Case Report ACROMEGALY OCCURRING IN A PATIENT WITH A PITUITARY ADENOMA, LYMPHOCYTIC HYPOPHYSITIS, AND A RATHKE CLEFT CYST Anupa Sharma, DO 1 ; Eric K.Richfield, MD, PhD 2 ; Sara E. Lubitz, MD 1 ABSTRACT
More informationSomatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234)
Somatotroph Pituitary Adenomas (Acromegaly) The Diagnostic Pathway (11-2K-234) Common presenting symptoms/clinical assessment: Pituitary adenomas are benign neoplasms of the pituitary gland. In patients
More informationHYPOTHALAMO PITUITARY GONADAL AXIS
HYPOTHALAMO PITUITARY GONADAL AXIS Physiology of the HPG axis Endogenous opioids and the HPG axis (exerciseinduced menstrual disturbances) Effects of the immune system on the HPG axis (cytokines: interleukins
More informationSilent ACTHoma: A subclinical presentation of Cushing s disease in a 79 year old male
575 Silent ACTHoma: A subclinical presentation of Cushing s disease in a 79 year old male Meenal Malviya 1, Navneet Kumar 1*, Naseer Ahmad 2 1 MD; Department of Internal Medicine, Providence Hospital &
More informationWhere Has My Vision Gone? Evaluation of Sellar Lesions. Caleb Stowell,, HMS III Gillian Lieberman, MD November 2008
Where Has My Vision Gone? Evaluation of Sellar Lesions Caleb Stowell,, HMS III Gillian Lieberman, MD November 2008 Objectives Present a case highlighting the clinical presentation and evaluation of a sellar
More informationIn clinical series, pituitary tumors are the third most. Incidental pituitary adenomas
Neurosurg Focus 31 (6):E18, 2011 Incidental pituitary adenomas Walavan Sivakumar, M.D., 1 Roukoz Chamoun, M.D., 1 Vinh Nguyen, M.D., 2 and William T. Couldwell, M.D., Ph.D. 1 Departments of 1 Neurosurgery
More informationPituitary adenomas and menopause
Pituitary adenomas and menopause Iulia Potorac Service d Endocrinologie Université de Liège CHU Liège RESULTATS Clinical case 1-38-year-old patient referred for exploration of premature ovarian failure
More informationPITUITARY PARASELLAR LESIONS. Kim Learned, MD
PITUITARY PARASELLAR LESIONS Kim Learned, MD DIFFERENTIALS Pituitary Sella Clivus, Sphenoid Sinus Suprasellar Optic chiasm, Hypothalamus, Circle of Willis Parasellar Cavernous Sinus Case 1 17 YEAR-OLD
More informationpanhypopituitarism Pattawan Wongwijitsook Maharat Nakhon Ratchasima hospital 17 Nov 2013
panhypopituitarism Pattawan Wongwijitsook Maharat Nakhon Ratchasima hospital 17 Nov 2013 PITUITARY GLAND (HYPOPHYSIS CEREBRI) The master of endocrine glands master of endocrine glands It is a small oval
More informationTHE ANTERIOR PITUITARY. Embryology cont. Embryology of the pituitary BY MISPA ZUH HS09A179. Embryology cont. THE PITUIYARY GLAND Anatomy:
THE ANTERIOR PITUITARY BY MISPA ZUH HS09A179 Embryology of the pituitary The pituitary is formed early in embryonic life from the fusion of the Rathke s pouch (anterior) and the diencephalon ( posterior)
More informationDepartment of Neurosurgery and The California Center for Pituitary Disorders, University of California, San Francisco, California
clinical article J Neurosurg 124:589 595, 2016 Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis
More informationJACK L. SNITZER, DO INTERNAL MEDICINE BOARD REVIEW COURSE 2018 PITUITARY
JACK L. SNITZER, DO INTERNAL MEDICINE BOARD REVIEW COURSE 2018 PITUITARY JACK L. SNITZER, D.O. Peninsula Regional Endocrinology 1415 S. Division Street Salisbury, MD 21804 Phone:410-572-8848 Fax:410-572-6890
More informationNon-Functioning Tumours and Pituitary Hormone Testing. Miguel Debono Consultant in Endocrinology
Non-Functioning Tumours and Pituitary Hormone Testing Miguel Debono Consultant in Endocrinology Agenda Pituitary masses Non functioning pituitary adenomas Testing pituitary function Pituitary Hormone Replacement
More information(3) Pituitary tumours
Hypopituitarism Diabetes Insipidus Pituitary tumours (2) Dr T Kemp - Endocrinology and Metabolism Unit - Steve Biko Academic Hospital (3) Pituitary tumours Pituitary microadenoma - intrasellar adenoma
More informationCase Report. Michael H. Goldman, MD; Alison T. Gruber; Marc A. Herman, MD ABSTRACT
Case Report CONCURRENT PANHYPOPITUITARISM AND HYPERPROLACTINEMIA DUE TO A GIANT INTERNAL CAROTID ANEURYSM REVEALED BY THYROID HORMONE WITHDRAWAL DURING FOLLOW-UP MANAGEMENT OF THYROID CANCER Michael H.
More informationPituitary adenomas in childhood and adolescence ISABELLE L. RICHMOND, M.D., PH.D., AND CHARLES B. WILSON, M.D.
J Neurosurg 49:163-168, 1978 Pituitary adenomas in childhood and adolescence ISABELLE L. RICHMOND, M.D., PH.D., AND CHARLES B. WILSON, M.D. Department of Neurological Surgery, University of California
More informationEnterprise Interest None
Enterprise Interest None Plurihormonal cells of normal anterior pituitary Lubov Mitrofanova¹, Petr Konovalov¹, Julia Krylova², Igor Kvetnoy² ¹Federal Almazov North-West Medical Research Centre, St. Petersburg,
More informationOriginal Article The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas
Int J Clin Exp Med 2015;8(10):18990-18997 www.ijcem.com /ISSN:1940-5901/IJCEM0010856 Original Article The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas Fangfang Zhang 1, Yinxing
More informationClinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(1):1-7 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.1.1 Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma
More information15 month-old female with a cystic brain lesion. Magdalena Dumin, MD Pediatric Endocrinology Fellow University of Chicago December 4, 2014
+ 15 month-old female with a cystic brain lesion Magdalena Dumin, MD Pediatric Endocrinology Fellow University of Chicago December 4, 2014 + Chief Complaint 15 month-old female admitted to PICU for concern
More informationX/00/$03.00/0 Vol. 85, No. 5 The Journal of Clinical Endocrinology & Metabolism Copyright 2000 by The Endocrine Society
0021-972X/00/$03.00/0 Vol. 85, No. 5 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2000 by The Endocrine Society The Dominant Role of Increased Intrasellar Pressure in
More informationPituitary Tumors: adenoma, craniopharyngioma, rathke cyst
Pituitary Tumors: adenoma, craniopharyngioma, rathke cyst Overview Tumors that grow from the pituitary gland can affect the whole body by interfering with normal hormone levels. They can also cause headaches
More informationLong-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure?
J Neurosurg (Suppl) 102:119 123, 2005 Long-term results of gamma knife surgery for growth hormone producing pituitary adenoma: is the disease difficult to cure? TATSUYA KOBAYASHI, M.D., PH.D., YOSHIMASA
More informationThe characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients
The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients Cheng Huan 1, Guihua Cui 2 and Zongming Ren 3 * 1 Department of Neurosurgery, Shandong
More informationAccepted Manuscript. Pituitary metastasis of breast cancer mimicking IgG4-related hypophysitis
Accepted Manuscript Pituitary metastasis of breast cancer mimicking IgG4-related hypophysitis Kanako Nose, Toshiyasu Ogata, Jun Tsugawa, Tooru Inoue, Kazuki Nabeshima, Yoshio Tsuboi PII: S2405-6502(18)30046-7
More informationClinical presentations of endocrine diseases
Section I Chapter 1 Clinical approaches Clinical presentations of endocrine diseases Karen Gomez-Hernandez and Shereen Ezzat Endocrinology is a fascinating field that covers a wide range of diseases with
More informationProcess / Evidence Class. Clinical Assessment / III
Table 2: Endocrine Author Cozzi et al (2009) 1 Study Design: Prospectively followed case series. Fourteen patients had pre-op hypocortisolism. Patient Population: Seventy-two adult patients who underwent
More informationInappropriate Secretion of Thyroid Stimulating Hormone in a Filipino Patient with a Pituitary Macroadenoma
114 Lermah S. unoy, et al Inappropriate Secretion of Thyroid Stimulating Hormone in a Filipino Patient Case Report Inappropriate Secretion of Thyroid Stimulating Hormone in a Filipino Patient with a Pituitary
More informationSkullbase Lesions. Skullbase Surgery Open vs endoscopic. Choice Of Surgical Approaches 12/28/2015. Skullbase Surgery: Evolution
Skullbase Lesions Skullbase Surgery Open vs endoscopic Prof Asim Mahmood,FRCS,FACS,FICS,FAANS, Professor of Neurosurgery Henry Ford Hospital Detroit, MI, USA Anterior Cranial Fossa Subfrontal meningioma
More informationCASE REPORT. SNI: Skull Base 2016, Vol 7: Suppl 16 - A Supplement to Surgical Neurology International S450
SNI: Skull Base, a supplement to Surgical Neurology International OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: James I. Ausman, MD, PhD University of California,
More informationCase Report A Rare Corticotroph-Secreting Tumor with Coexisting Prolactin and Growth Hormone Staining Cells
Case Reports in Endocrinology Volume 2012, Article ID 529730, 5 pages doi:10.1155/2012/529730 Case Report A Rare Corticotroph-Secreting Tumor with Coexisting Prolactin and Growth Hormone Staining Cells
More informationThe reproductive system
The reproductive system THE OVARIAN CYCLE HORMONAL REGULATION OF OOGENSIS AND OVULATION hypothalamic-pituitary-ovary axis Overview of the structures of the endocrine system Principal functions of the
More informationPituitary for the General Practitioner. Marilyn Lee Consultant physician and endocrinologist
Pituitary for the General Practitioner Marilyn Lee Consultant physician and endocrinologist Pituitary tumours Anterior/posterior pituitary Extension of adenoma upwards/downwards/sideways Producing too
More informationBrain Tumors. Andrew J. Fabiano, MD FAANS. Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine
Brain Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases Brain
More informationSurgical therapeutic strategy for giant pituitary adenomas.
Biomedical Research 2017; 28 (19): 8284-8288 ISSN 0970-938X www.biomedres.info Surgical therapeutic strategy for giant pituitary adenomas. Han-Shun Deng, Zhi-Quan Ding, Sheng-fan Zhang, Zhi-Qiang Fa, Qing-Hua
More informationWhat we will cover. Evaluation of the Child with Suspected Pituitary Disease. ituitary
Evaluation of the Child with Suspected Pituitary Disease Craig Alter, MD University of Pennsylvania Children s Hospital of Philadelphia What we will cover * What laboratory tests to order * MRI: common
More informationENDOCRINE OUTCOMES OF TRANS-SPHENOIDAL SURGERY FOR PITUITARY APOPLEXY VERSUS ELECTIVE SURGERY FOR PITUITARY ADENOMA
ENDOCRINE PRACTICE Rapid Electronic Article in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited, typeset
More informationDIAGNOSTIC AND THERAPEUTIC APPROACH TO PITUITARY INCIDENTALOMAS. Anastasios N. Mavrakis, MD, 1 and Nicholas A. Tritos, MD, DSc, MMSc, FACE, FACP 2
Review Article DIAGNOSTIC AND THERAPEUTIC APPROACH TO PITUITARY INCIDENTALOMAS Anastasios N. Mavrakis, MD, 1 and Nicholas A. Tritos, MD, DSc, MMSc, FACE, FACP 2 ABSTRACT Objective: To review data on epidemiology,
More informationPituitary Adenoma Apoplexy: Review of Personal Series
Original Article Pituitary Adenoma Apoplexy: Review of Personal Series Abstract Background: Pituitary apoplexy is a life threatening event with unspecific clinical background and no standardized treatment.
More informationAutoimmune hypophysitis may eventually become empty sella
Neuroendocrinology Letters Volume 34 No. 2 2013 Autoimmune hypophysitis may eventually become empty sella Hua Gao*, You-you Gu*, Ming-cai Qiu Department of Endocrinology, Tianjin Medical University General
More informationIs Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?
DOI: 10.137/1019-149.JTN.14889-1.1 Received: 01.0.201 / Accepted: 14.08.201 Published Online: 14.04.2016 Original Investigation Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing
More informationClinical significance of thickened sphenoid sinus mucosa in Rathke s cleft cyst
SNI: General Neurosurgery OPEN ACCESS For entire Editorial Board visit : http://www.surgicalneurologyint.com Editor: C. David Hunt, M.D. Marquette General Neurosurgery, Brooklyn, NY, USA Original Article
More informationTREATMENT OF CUSHING S DISEASE
TREATMENT OF CUSHING S DISEASE Surgery, Radiation, Medication Peter J Snyder, MD Professor of Medicine Disclosures Novartis Research grant Pfizer Consultant Ipsen Research grant Cortendo Research grant
More informationPituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs
Pituitary, Parathyroid Pheochromocytomas & Paragangliomas: The 4 Ps of NETs Shereen Ezzat, MD, FRCP(C), FACP Professor Of Medicine & Oncology Head, Endocrine Oncology Princess Margaret Hospital/University
More informationPITUITARY ADENOMAS. Effective Date: August, 2012
CLINICAL PRACTICE GUIDELINE CNS-00 PITUITARY ADENOMAS Effective Date: August, 2012 The recommendations contained in this guideline are a consensus of the Alberta Provincial CNS Tumour Team synthesis of
More informationPituitary Apoplexy. Updated: April 22, 2018 CLINICAL RECOGNITION
Pituitary Apoplexy Zeina C Hannoush, MD. Assistant Professor of Clinical Medicine. Division of Endocrinology, Diabetes and Metabolism. University of Miami, Miller School of Medicine. Roy E Weiss, MD, PhD,
More informationCase Studies in Sella/Parasellar Region. Child thirsty, increased urination. Imaging. Suprasellar Germ Cell Tumor (Germinoma) No Disclosures
Case Studies in Sella/Parasellar Region No Disclosures 2018 Head and Neck Imaging Conference Child thirsty, increased urination Suprasellar Germ Cell Tumor (Germinoma) Midline Pineal >> Suprasellar > Other
More informationMetoclopramide Domperidone. HYPER- PROLACTINAEMIA: the true and the false problems
Modern management of Hyperprolactinaemia Didier DEWAILLY, M.D. Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre, C.H.R.U., 59037 Lille, France 1 Metoclopramide Domperidone
More informationBrain and Spine Tumors
Brain and Spine Tumors Andrew J. Fabiano, MD FAANS Associate Professor of Neurosurgery Roswell Park Cancer Institute SUNY at Buffalo School of Medicine Brain Tumors Brain Tumor Basics Types of Tumors Cases
More informationIntroduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly
Introduction to Endocrinology. Hypothalamic and Pituitary diseases Prolactinoma + Acromegaly Dr. Peter Igaz MD PhD DSc 2nd Department of Medicine Semmelweis University Fields of Endocrinology Diseases
More informationCollision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region
Jin et al. World Journal of Surgical Oncology 2013, 11:178 WORLD JOURNAL OF SURGICAL ONCOLOGY CASE REPORT Open Access Collision tumors of the sella: coexistence of pituitary and in the sellar region Guishan
More informationEXPERT DIFFERENTIAL DIAGNOSIS:
EXPERT DIFFERENTIAL DIAGNOSIS: Sellar Region Anne G. Osborn, M.D. DISCLOSURE: Published RSNA 2008 SELLA, PITUITARY: Normal Gross, 3T Anatomy SELLA, PITUITARY: Anatomically-Based Differential Diagnoses
More informationImpact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined Approach
Radiosurgery as part of the neurosurgical armamentarium: Educational Symposium November 24 th 2011 Impact of Gamma Knife Radiosurgery on the neurosurgical management of skull-base lesions: The Combined
More informationPituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report
ISSN 1941-5923 DOI: 10.12659/AJCR.901032 Received: 2016.08.12 Accepted: 2016.10.17 Published: 2017.01.03 Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report Authors Contribution:
More informationMRI of the Pituitary Gland
MRI of the Pituitary Gland Jean- François Bonneville Fabrice Bonneville Françoise Cattin Sonia Nagi MRI of the Pituitary Gland With a Foreword by A. Beckers Jean-François Bonneville, MD Department of
More informationStandardized Thyroid Cancer Mortality in Korea between 1985 and 2010
Original Article Endocrinol Metab 2014;29:530-535 http://dx.doi.org/10.3803/enm.2014.29.4.530 pissn 2093-596X eissn 2093-5978 Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010 Yun Mi
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More informationThe Importance of Immunohistochemical Analysis in Silent Pituitary Adenoma. Intern at Siloam Hospital Lippo Village, Banten, Indonesia 2
Case Report The Importance of Immunohistochemical Analysis in Silent Pituitary Adenoma Ivan William Harsono 1, Nathania Victoria Stevina 1, Vivien Puspitasari 2, Julius July 3 1 Intern at Siloam Hospital
More informationIn some patients with pituitary macroadenoma, visual acuity
ORIGINAL RESEARCH A.M. Tokumaru I. Sakata H. Terada S. Kosuda H. Nawashiro M. Yoshii Optic Nerve Hyperintensity on T2-Weighted Images among Patients with Pituitary Macroadenoma: Correlation with Visual
More informationDisclosures. BMS, Ferring research grant funding NovoNordisk scientific advisory board Chiasma clinical trial investigator
Pituitary Disorders Ursula B. Kaiser, M.D. Chief, Division of Endocrinology, Diabetes, and Hypertension Brigham and Women s Hospital Professor of Medicine Harvard Medical School Disclosures BMS, Ferring
More informationEvaluation and management of pituitary incidentalomas
REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: To outline an approach to the workup and management of patients with incidentally discovered pituitary masses DINA SERHAL, MD Department of Endocrinology, Diabetes,
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More informationAntidiuretic Hormone
1 Antidiuretic Hormone 2 Physiology of the Posterior Pituitary The posterior pituitary gland secretes two hormones which are: oxytocin, increase uterine contractions during parturition Contraction of mammary
More informationOriginal Article. Abstract. Introduction. Thinesh Kumran 1,2, Saffari Haspani 1,2, Jafri Malin Abdullah 1,4, Azmi Alias 1,2, Fan Rui Ven 3
Original Article Factors Influencing Disconnection Hyperprolactinemia and Reversal of Serum Prolactin after Pituitary Surgery in a Non-Functioning Pituitary Macroadenoma Thinesh Kumran 1,2, Saffari Haspani
More informationPituitary Disorders Pearls
Disclosures Pituitary Disorders Pearls Whitney Woodmansee M.D. Director, Clinical Neuroendocrine Program Brigham and Women s Hospital / Harvard Medical School Boston, MA July 21, 2012 Eli Lilly and Company-
More informationPredicting the Size of Benign Thyroid Nodules and Analysis of Associated Factors That Affect Nodule Size
Original Article www.cmj.ac.kr Predicting the Size of Benign Thyroid Nodules and Analysis of Associated Factors That Affect Nodule Size Seok Ho Seo, Tae Hyun Kim*, Soon Ho Kim, Seung Hyun Lee, Jong Taek
More informationA Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease
A Combined Case of Macroprolactinoma, Growth Hormone Excess and Graves' Disease Z Hussein, MRCP*, B Tress**, P G Cohnan, FRACP***... 'Department of Medicine, Hospital Putrajaya, Putrajaya, Presint 7, 62250
More informationPituitary gland Pituitary fossa Mass: 5 gms DIMENSIONS 7mm (Ht) 9mm (AP) 11m(transverse) originates from Rathke s pouch and infundibulum
Pituitary gland Pituitary fossa Mass: 5 gms DIMENSIONS 7mm (Ht) 9mm (AP) 11m(transverse) originates from Rathke s pouch and infundibulum Cell type hormone Clinical syndrome Tumor type Somatotroph Growth
More information